All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WJ2173 | Anti-ZHX2 (CBWJZ-088) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJZ-088 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2174 | Anti-ZHX2 (CBWJZ-089) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJZ-089 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2175 | Anti-ZHX2 (5E2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 5E2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2176 | Anti-ZHX2 (CBWJZ-091) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJZ-091 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2177 | Anti-ZHX2 (CBWJZ-090) h(41BB-CD3ζ) CAR, pCDCAR1 | CBWJZ-090 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ4465 | Anti-ZHX2 (CBWJZ-088) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJZ-088 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4466 | Anti-ZHX2 (CBWJZ-089) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJZ-089 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4467 | Anti-ZHX2 (5E2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 5E2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4468 | Anti-ZHX2 (CBWJZ-091) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJZ-091 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4469 | Anti-ZHX2 (CBWJZ-090) h(CD28-CD3ζ) CAR, pCDCAR1 | CBWJZ-090 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION